Agoulnik I - Search Results

1

Pim-2 upregulation: biological implications associated with disease progression and perinueral invasion in prostate cancer.

Dai H, Li R, Wheeler T, Diaz de Vivar A, Frolov A, Tahir S, Agoulnik I, Thompson T, Rowley D, Ayala G. Dai H, et al. Among authors: agoulnik i. Prostate. 2005 Nov 1;65(3):276-86. doi: 10.1002/pros.20294. Prostate. 2005. PMID: 16015593

2

Repressors of androgen and progesterone receptor action.

Agoulnik IU, Krause WC, Bingman WE 3rd, Rahman HT, Amrikachi M, Ayala GE, Weigel NL. Agoulnik IU, et al. J Biol Chem. 2003 Aug 15;278(33):31136-48. doi: 10.1074/jbc.M305153200. Epub 2003 May 27. J Biol Chem. 2003. PMID: 12771131 Free article.

3

Androgen receptor signaling and vitamin D receptor action in prostate cancer cells.

Murthy S, Agoulnik IU, Weigel NL. Murthy S, et al. Prostate. 2005 Sep 1;64(4):362-72. doi: 10.1002/pros.20251. Prostate. 2005. PMID: 15754350

4

Role of SRC-1 in the promotion of prostate cancer cell growth and tumor progression.

Agoulnik IU, Vaid A, Bingman WE 3rd, Erdeme H, Frolov A, Smith CL, Ayala G, Ittmann MM, Weigel NL. Agoulnik IU, et al. Cancer Res. 2005 Sep 1;65(17):7959-67. doi: 10.1158/0008-5472.CAN-04-3541. Cancer Res. 2005. PMID: 16140968

5

Androgens modulate expression of transcription intermediary factor 2, an androgen receptor coactivator whose expression level correlates with early biochemical recurrence in prostate cancer.

Agoulnik IU, Vaid A, Nakka M, Alvarado M, Bingman WE 3rd, Erdem H, Frolov A, Smith CL, Ayala GE, Ittmann MM, Weigel NL. Agoulnik IU, et al. Cancer Res. 2006 Nov 1;66(21):10594-602. doi: 10.1158/0008-5472.CAN-06-1023. Cancer Res. 2006. PMID: 17079484

6

Relaxin promotes prostate cancer progression.

Feng S, Agoulnik IU, Bogatcheva NV, Kamat AA, Kwabi-Addo B, Li R, Ayala G, Ittmann MM, Agoulnik AI. Feng S, et al. Among authors: agoulnik ai, agoulnik iu. Clin Cancer Res. 2007 Mar 15;13(6):1695-702. doi: 10.1158/1078-0432.CCR-06-2492. Clin Cancer Res. 2007. PMID: 17363522

7

Relaxin/RXFP1 signaling in prostate cancer progression.

Feng S, Agoulnik IU, Li Z, Han HD, Lopez-Berestein G, Sood A, Ittmann MM, Agoulnik AI. Feng S, et al. Among authors: agoulnik ai, agoulnik iu. Ann N Y Acad Sci. 2009 Apr;1160:379-80. doi: 10.1111/j.1749-6632.2008.03793.x. Ann N Y Acad Sci. 2009. PMID: 19416223 Free PMC article.

8

Suppression of relaxin receptor RXFP1 decreases prostate cancer growth and metastasis.

Feng S, Agoulnik IU, Truong A, Li Z, Creighton CJ, Kaftanovskaya EM, Pereira R, Han HD, Lopez-Berestein G, Klonisch T, Ittmann MM, Sood AK, Agoulnik AI. Feng S, et al. Among authors: agoulnik ai, agoulnik iu. Endocr Relat Cancer. 2010 Oct 29;17(4):1021-33. doi: 10.1677/ERC-10-0073. Print 2010 Dec. Endocr Relat Cancer. 2010. PMID: 20861284

9

Decreased expression and androgen regulation of the tumor suppressor gene INPP4B in prostate cancer.

Hodgson MC, Shao LJ, Frolov A, Li R, Peterson LE, Ayala G, Ittmann MM, Weigel NL, Agoulnik IU. Hodgson MC, et al. Cancer Res. 2011 Jan 15;71(2):572-82. doi: 10.1158/0008-5472.CAN-10-2314. Epub 2011 Jan 11. Cancer Res. 2011. PMID: 21224358 Free PMC article.

10

Nuclear Receptor Corepressor 1 Expression and Output Declines with Prostate Cancer Progression.

Lopez SM, Agoulnik AI, Zhang M, Peterson LE, Suarez E, Gandarillas GA, Frolov A, Li R, Rajapakshe K, Coarfa C, Ittmann MM, Weigel NL, Agoulnik IU. Lopez SM, et al. Among authors: agoulnik ai, agoulnik iu. Clin Cancer Res. 2016 Aug 1;22(15):3937-49. doi: 10.1158/1078-0432.CCR-15-1983. Epub 2016 Mar 11. Clin Cancer Res. 2016. PMID: 26968201 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

64 results

Search Page

Filters